Cargando…

Prognostic influences of B-cell lymphoma 2–positive expression on late recurrence in breast cancer

PURPOSE: B-cell lymphoma 2 (BCL2) has an antiapoptotic role, however, has resulted in it being a powerful favorable prognostic factor in breast cancer. Several studies revealed BCL2 is strongly associated with a lower rate of early recurrence after initial treatment in breast cancer patients, but st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Hee Ju, Eom, Yong Hwa, Choi, Seung Hye
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Surgical Society 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333802/ https://www.ncbi.nlm.nih.gov/pubmed/37441325 http://dx.doi.org/10.4174/astr.2023.105.1.20

Ejemplares similares

The different prognostic impact of age according to individual molecular subtypes in breast cancer
por: Kim, Nam Hee, et al.
Publicado: (2022)

The Difference in Prognostic Factors between Early Recurrence and Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Nodal Stage Differently Impacts Early and Late Recurrence
por: Ahn, Sung Gwe, et al.
Publicado: (2013)

Clinical outcomes and prognostic factors in patients with breast diffuse large B cell lymphoma; Consortium for Improving Survival of Lymphoma (CISL) study
por: Yhim, Ho-Young, et al.
Publicado: (2010)

Dynamic contrast-enhanced breast magnetic resonance imaging for the prediction of early and late recurrences in breast cancer
por: Choi, Eun Jung, et al.
Publicado: (2016)

Clonal relationships in recurrent B-cell lymphomas
por: Lee, Seung Eun, et al.
Publicado: (2016)

Factors Predicting Late Recurrence for Estrogen Receptor–Positive Breast Cancer
por: Sestak, Ivana, et al.
Publicado: (2013)

The Risk Factors Influencing between the Early and Late Recurrence in Systemic Recurrent Breast Cancer
por: Song, Won Jong, et al.
Publicado: (2012)

Prognostic factors after isolated ipsilateral local and regional recurrence in HER2-negative luminal breast cancer: a multi-center retrospective study
por: Eom, Yong Hwa, et al.
Publicado: (2023)

Improved prognostic stratification using NCCN- and GELTAMO-international prognostic index in patients with diffuse large B-cell lymphoma
por: Hong, Junshik, et al.
Publicado: (2017)

Toronto Workshop on Late Recurrence in Estrogen Receptor–Positive Breast Cancer: Part 1: Late Recurrence: Current Understanding, Clinical Considerations
por: Dowling, Ryan J O, et al.
Publicado: (2019)

Metastatic breast cancer from a hepatocellular carcinoma: a case report
por: Bang, Hyewon, et al.
Publicado: (2022)

Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 2: Approaches to Predict and Identify Late Recurrence, Research Directions
por: Dowling, Ryan J O, et al.
Publicado: (2019)

Diffuse large B-cell lymphoma of the breast: prognostic factors and treatment outcomes
por: Sun, Yao, et al.
Publicado: (2016)

Young Age Is Associated with Increased Locoregional Recurrence in Node-Positive Breast Cancer with Luminal Subtypes
por: Kim, Sang-Won, et al.
Publicado: (2017)

BCL2 as a Subtype-Specific Prognostic Marker for Breast Cancer
por: Eom, Yong Hwa, et al.
Publicado: (2016)

HER2-Positive Conversion in a Metastatic Liver Focus in Late Recurrent Breast Cancer
por: Kitahara, Miyuki, et al.
Publicado: (2019)

TGF-β/IL-7 Chimeric Switch Receptor-Expressing CAR-T Cells Inhibit Recurrence of CD19-Positive B Cell Lymphoma
por: Noh, Kyung-Eun, et al.
Publicado: (2021)

Markers for the identification of late breast cancer recurrence
por: Sestak, Ivana, et al.
Publicado: (2015)

Epstein-Barr virus-positive diffuse large B-cell lymphoma with human immunodeficiency virus mimicking complicated frontal sinusitis: A case report
por: Yoon, Seokho, et al.
Publicado: (2021)

Prognostic significance of BLK expression in R-CHOP treated diffuse large B-cell lymphoma
por: Choi, Soyeon, et al.
Publicado: (2022)

The ELEANOR noncoding RNA expression contributes to cancer dormancy and predicts late recurrence of estrogen receptor‐positive breast cancer
por: Fukuoka, Megumi, et al.
Publicado: (2022)

In-depth circulating tumor DNA sequencing for prognostication and monitoring in natural killer/T-cell lymphomas
por: Kim, Jin Ju, et al.
Publicado: (2023)

Late recurrence of Burkitt’s lymphoma in the jaw: numb chin syndrome as the only symptom
por: Benites, Bernar Monteiro, et al.
Publicado: (2020)

Prediction of Late Breast Cancer-Specific Mortality in Recurrence-Free Breast Cancer Survivors Treated for Five Years with Tamoxifen
por: Baek, Soo Yeon, et al.
Publicado: (2019)

Early Interim Chemotherapy Response Evaluation by F-18 FDG PET/CT in Diffuse Large B Cell Lymphoma
por: Park, Hye Lim, et al.
Publicado: (2020)

Factors associated with late recurrence after completion of 5-year adjuvant tamoxifen in estrogen receptor positive breast cancer
por: Lee, Eun-Shin, et al.
Publicado: (2016)

HDAC1 Expression in Invasive Ductal Carcinoma of the Breast and Its Value as a Good Prognostic Factor
por: Eom, Minseob, et al.
Publicado: (2012)

The prognostic significance of CD11b(+)CX3CR1(+) monocytes in patients with newly diagnosed diffuse large B-cell lymphoma
por: Yhim, Ho-Young, et al.
Publicado: (2017)

Predictive biological factors for late survival in patients with HER2-positive breast cancer
por: Kang, Young-Joon, et al.
Publicado: (2023)

Predictive and Prognostic Value of the 21-Gene Recurrence Score in Hormone Receptor–positive, Node-positive Breast Cancer
por: Brufsky, Adam M.
Publicado: (2014)

Prognostic Discrimination Using a 70-Gene Signature among Patients with Estrogen Receptor-Positive Breast Cancer and an Intermediate 21-Gene Recurrence Score
por: Ahn, Sung Gwe, et al.
Publicado: (2013)

Late recurrence of lymphoid malignancies after initial treatment for Hodgkin lymphoma – A study from the Danish Lymphoma Registry
por: Andersen, Maja Dam, et al.
Publicado: (2022)

Clinical significance of cytogenetic aberrations in bone marrow of patients with diffuse large B-cell lymphoma: prognostic significance and relevance to histologic involvement
por: Kim, Seon Young, et al.
Publicado: (2013)

Clinical Characteristics and Prognostic Factors in Primary Breast Diffuse Large B-Cell Lymphoma
por: Chen, Guang-Liang, et al.
Publicado: (2022)

High expression of SLC20A1 is less effective for endocrine therapy and predicts late recurrence in ER-positive breast cancer
por: Onaga, Chotaro, et al.
Publicado: (2022)

Clinical Implications of Serum 25-Hydroxyvitamin D Status after 5-Year Adjuvant Endocrine Therapy for Late Recurrence of Hormone Receptor-positive Breast Cancer
por: Lim, Seung Taek, et al.
Publicado: (2020)

Prognostic factors for tumor recurrence in endometrioid endometrial cancer stages IA and IB
por: Han, Kyung Hee, et al.
Publicado: (2017)

The mutation of BCOR is highly recurrent and oncogenic in mature T-cell lymphoma
por: Kang, Jin Hyun, et al.
Publicado: (2021)

Genetic heterogeneity and prognostic impact of recurrent ANK2 and TP53 mutations in mantle cell lymphoma: a multi-centre cohort study
por: Jeong, Seri, et al.
Publicado: (2020)

Very Late Recurrence in Breast Cancer: Is Breast Cancer a Chronic Disease?
por: Kamata, Arimichi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_au0nbnnldiu1r0jkq6u3rtt85c